BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 27095464)

  • 1. Childhood opsoclonus-myoclonus syndrome: diagnosis and treatment.
    Blaes F; Dharmalingam B
    Expert Rev Neurother; 2016 Jun; 16(6):641-8. PubMed ID: 27095464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New autoantibodies in pediatric opsoclonus myoclonus syndrome.
    Kirsten A; Beck S; Fühlhuber V; Kaps M; Kreutz T; Korfei M; Schmitt S; Preissner KT; Blaes F
    Ann N Y Acad Sci; 2007 Sep; 1110():256-60. PubMed ID: 17911440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood opsoclonus-myoclonus syndrome: A case series from Tunisia.
    Ben Achour N; Mrabet S; Rebai I; Abid I; Benrhouma H; Klaa H; Rouissi A; Kraoua I; Ben Youssef Turki I
    Brain Dev; 2017 Oct; 39(9):751-755. PubMed ID: 28549713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Opsoclonus myoclonus ataxia syndrome in Israel].
    Blumkin L; Lerman-Sagie T
    Harefuah; 2010 Jan; 149(1):24-8, 63. PubMed ID: 20422836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS).
    Krasenbrink I; Fühlhuber V; Juhasz-Boess I; Stolz E; Hahn A; Kaps M; Hero B; Blaes F
    Neuropediatrics; 2007 Jun; 38(3):114-6. PubMed ID: 17985258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Opsoclonus-myoclonus syndrome in a 2 year old boy with prenatally diagnosed retroperitoneal tumour].
    Jamroz E; Głuszkiewicz E; Madziara W; Kiełtyka A
    Med Wieku Rozwoj; 2011; 15(2):151-6. PubMed ID: 22002047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsoclonus-myoclonus Syndrome with Neuroblastoma in Children and their Anaesthetic Management.
    Gupta A; Kundal R; Pandey M
    J Coll Physicians Surg Pak; 2022 Aug; 32(8):1086-1088. PubMed ID: 35932142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical profile and outcome of children with opsoclonus-myoclonus syndrome.
    Singhi P; Sahu JK; Sarkar J; Bansal D
    J Child Neurol; 2014 Jan; 29(1):58-61. PubMed ID: 23318697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Paraneoplastic opsoclonus-myoclonus syndrome--a review].
    Matsumoto H; Ugawa Y
    Brain Nerve; 2010 Apr; 62(4):365-9. PubMed ID: 20420176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paraneoplastic opsoclonus-myoclonus syndrome (POMS)].
    Matsumoto H; Ugawa Y
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():763-7. PubMed ID: 26480791
    [No Abstract]   [Full Text] [Related]  

  • 11. Opsoclonus-myoclonus syndrome following rotavirus gastroenteritis.
    Gurkas E; Gucuyener K; Yılmaz U; Havalı C; Demir E
    Pediatr Int; 2014 Dec; 56(6):e86-e87. PubMed ID: 25521990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opsoclonus-myoclonus syndrome associated with pancreatic neuroendocrine tumor: a case report.
    Reinecke R; Reiländer A; Seiler A; Koch C; Voss M
    BMC Neurol; 2022 Dec; 22(1):507. PubMed ID: 36581905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG subclass distribution of autoantibodies in pediatric opsoclonus-myoclonus syndrome.
    Beck S; Fühlhuber V; Krasenbrink I; Tschernatsch M; Kneifel N; Kirsten A; Jaeger C; Kaps M; Preissner KT; Lang B; Rostasy K; Blaes F
    J Neuroimmunol; 2007 Apr; 185(1-2):145-9. PubMed ID: 17324472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies in childhood opsoclonus-myoclonus syndrome.
    Blaes F; Pike MG; Lang B
    J Neuroimmunol; 2008 Sep; 201-202():221-6. PubMed ID: 18687475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The opsoclonus–myoclonus syndrome.
    Sahu JK; Prasad K
    Pract Neurol; 2011 Jun; 11(3):160-6. PubMed ID: 21551110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifactorial analysis of opsoclonus-myoclonus syndrome etiology ("Tumor" vs. "No tumor") in a cohort of 356 US children.
    Pranzatelli MR; Tate ED; McGee NR
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27097. PubMed ID: 29727049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma.
    Burke MJ; Cohn SL
    Pediatr Blood Cancer; 2008 Mar; 50(3):679-80. PubMed ID: 16900484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK Cell-mediated Neuroblastoma Cell Lysis is Enhanced by IgG From Patients With Pediatric Opsoclonus-Myoclonus Syndrome.
    Zar T; Tschernatsch M; Hero B; Lang B; Preissner KT; Blaes F
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):e176-e179. PubMed ID: 33060390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of autoantigens in pediatric opsoclonus-myoclonus syndrome.
    Blaes F; Fühlhuber V; Preissner KT
    Expert Rev Clin Immunol; 2007 Nov; 3(6):975-82. PubMed ID: 20477144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute transverse myelitis following an opsoclonus-myoclonus syndrome: An unusual presentation.
    Simon T; Cheuret E; Fiedler L; Mengelle C; Baudou E; Deiva K
    Eur J Paediatr Neurol; 2018 Sep; 22(5):878-881. PubMed ID: 29773357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.